Dendritic Cell Vaccine With Imiquimod for Patients With Malignant Glioma

Clinical trial NCT01792505 · COMPLETED

Trial details

NCT number: NCT01792505
Sponsor: Cedars-Sinai Medical Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Glioma

Start date: 2009-10-01
Primary completion: 2014-11-14
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.